The role of MIZ-1 in MYC-dependent tumorigenesis

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 12, 2013, Pages

  Wiese, Katrin E ^a   Walz, Susanne ^a   Von Eyss, Bjorn ^a   Wolf, Elmar ^a   Athineos, Dimitris ^b   Sansom, Owen ^b   Eilers, Martin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MIZ 1 PROTEIN; MYC PROTEIN; PEPTIDES AND PROTEINS; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR; ZBTB17 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELLULAR STRESS RESPONSE; COLON CARCINOMA; DNA DAMAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; LYMPHOMATOSIS; MOUSE MODEL; NONHUMAN; ONCOGENE C MYC; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKIN PAPILLOMA; TRANSCRIPTION INITIATION; TUMOR MODEL; ANIMAL; COLON TUMOR; EXPERIMENTAL CNS AUTOIMMUNE DISEASE; GENE DELETION; GENETICS; LYMPHOMA; MOUSE; ONCOGENE MYC; PAPILLOMA; PHYSIOLOGY; REVIEW; SKIN TUMOR;

ANIMALS; CARCINOGENESIS; COLONIC NEOPLASMS; GENE DELETION; GENES, MYC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOMA; MICE; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; PAPILLOMA; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84885032870     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a014290     Document Type: Article

References (56)

1. Adhikary S, Peukert K, Karsunky H, Beuger V, Lutz W, Elsasser HP, Moroy T, Eilers M. 2003. Miz1 is required for early embryonic development during gastrulation. Mol Cell Biol 23: 7648-7657.
2. Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, et al. 2005. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123: 409-421.
3. Bagchi A, Mills AA. 2008. The quest for the 1p36 tumor suppressor. Cancer Res 68: 2551-2556.
4. INK4B through interaction with Miz1. Proc Natl Acad Sci 106: 1433-1438.
5. Boone DN, Qi Y, Li Z, Hann SR. 2011. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci 108: 632-637.
6. Brenner C, Deplus R, Didelot C, Loriot A, Vire E, De Smet C, Gutierrez A, Danovi D, Bernard D, Boon T, et al. 2005. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J 24: 336-346.
7. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY, Wu J, Nakayama KI, Kang HY, Huang HY, et al. 2010. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 12: 457-467.
8. Colombo E, Alcalay M, Pelicci PG. 2011. Nucleophosmin and its complex network: A possible therapeutic target in hematological diseases. Oncogene 30: 2595-2609.
9. Conacci-Sorrell M, McFerrin L, Eisenman RN. 2014. An overview of MYC and its interactome. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014357.
10. Corvetta D, Chayka O, Gherardi S, D'Acunto CW, Cantilena S, Valli E, Piotrowska I, Perini G, Sala A. 2013. Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implications. J Biol Chem 288: 8332-8341.
11. Farrell AS, Sears RC. 2014. MYC degradation. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a014365.
12. Gebhardt A, Frye M, Herold S, Benitah SA, Braun K, Samans B, Watt FM, Elsasser HP, Eilers M. 2006. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J Cell Biol 172: 139-149.
13. Gebhardt A, Kosan C, Herkert B, Moroy T, Lutz W, Eilers M, Elsasser HP. 2007. Miz1 is required for hair follicle structure and hair morphogenesis. J Cell Sci 120: 2586-2593.
14. Herkert B, Dwertmann A, Herold S, Abed M, Naud JF, Finkernagel F, Harms GS, Orian A, Wanzel M, Eilers M. 2010. The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. J Cell Biol 188: 905-918.
15. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T, Syvaoja J, Saluz HP, Haenel F, Eilers M. 2002. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 10: 509-521.
16. Herold S, Hock A, Herkert B, Berns K, Mullenders J, Beijersbergen R, Bernards R, Eilers M. 2008. Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. EMBO Jl 27: 2851-2861.
17. Honnemann J, Sanz-Moreno A, Wolf E, Eilers M, Elsasser HP. 2012. Miz1 is a critical repressor of cdkn1a during skin tumorigenesis. PLoS ONE 7: e34885.
18. Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H, Rappaport EF, Hicks SL, Seeger RC, Tang XX. 2007. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene. Clin Cancer Res 13: 6001-6009.
19. Inoue S, Hao Z, Elia AJ, Cescon D, Zhou L, Silvester J, Snow B, Harris IS, Sasaki M, Li WY, et al. 2013. Mule/Huwe1/ Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15. Genes Dev 27: 1101-1114.
20. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 12: 1151-1164.
21. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. 2003. Skp2 regulates myc protein stability and activity. Mol Cell 11: 1177-1188.
22. Kosan C, Saba I, Godmann M, Herold S, Herkert B, Eilers M, Moroy T. 2010. Transcription factor miz-1 is required to regulate interleukin-7 receptor signaling at early commitment stages of B cell differentiation. Immunity 33: 917-928.
23. Li Z, Boone D, Hann SR. 2008. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc Natl Acad Sci 105: 18794-18799.
24. Licchesi JD, Van Neste L, Tiwari VK, Cope L, Lin X, Baylin SB, Herman JG. 2010. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene 29: 5923-5934.
25. Liu J, Zhao Y, Eilers M, Lin A. 2009. Miz1 is a signaland pathway-specific modulator or regulator (SMOR) that suppresses TNF-a-induced JNK1 activation. Proc Natl Acad Sci 106: 18279-18284.
26. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ, Bishop JM. 2012a. MYC suppresses cancer metastasis by direct transcriptional silencing of av and b3 integrin subunits. Nat Cell Biol 14: 567-574.
27. Liu J, Yan J, Jiang S, Wen J, Chen L, Zhao Y, Lin A. 2012b. Site-specific ubiquitination is required for relieving the transcription factor Miz1-mediated suppression on TNF-a-induced JNK activation and inflammation. Proc Natl Acad Sci 109: 191-196.
28. Moroy T, Saba I, Kosan C. 2011. The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-binding Myc makes the difference. Seminars Immunol 23: 379-387.
29. Oskarsson T, Essers MA, Dubois N, Offner S, Dubey C, Roger C, Metzger D, Chambon P, Hummler E, Beard P, et al. 2006. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes Dev 20: 2024-2029.
30. Patel JH, McMahon SB. 2006. Targeting of Miz-1 is essential for Myc-mediated apoptosis. J Biol Chem 281: 3283-3289.
31. Patel JH, McMahon SB. 2007. BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis. J Biol Chem 282: 5-13.
32. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M. 1997. An alternative pathway for gene regulation by Myc. EMBO J 16: 5672-5686.
33. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. 2005. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 6: 1054-1060.
34. ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431: 712-717.
35. Reimann M, Lee S, Loddenkemper C, Dörr JR, Tabor V, Aichele P, Stein H, Dörken B, Jenuwein T, Schmitt CA. 2010. Tumor stroma-derived TGF-b limits Myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell 17: 262-272.
36. Saba I, Kosan C, Vassen L, Moroy T. 2011. IL-7R-dependent survival and differentiation of early T-lineage progenitors is regulated by the BTB/POZ domain transcription factor Miz-1. Blood 117: 3370-3381.
37. Saito M, Novak U, Piovan E, Basso K, Sumazin P, Schneider C, Crespo M, Shen Q, Bhagat G, Califano A, et al. 2009. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci 106: 11294-11299.
38. Salghetti SE, Kim SY, Tansey WP. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J 18: 717-726.
39. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. 2007. Myc deletion rescues Apc deficiency in the small intestine. Nature 446: 676-679.
40. Savino M, Annibali D, Carucci N, Favuzzi E, Cole MD, Evan GI, Soucek L, Nasi S. 2011. The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy. PLoS ONE 6: e22284.
41. Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
42. Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, Karnezis AN, Swigart LB, Nasi S, Evan GI. 2008. Modelling Myc inhibition as a cancer therapy. Nature 455: 679-683.
43. INK4b expression by Myc through association with Miz-1. Nat Cell Biol 3: 392-399.
44. Stead MA, Trinh CH, Garnett JA, Carr SB, Baron AJ, Edwards TA, Wright SC. 2007. A b-sheet interaction interface directs the tetramerisation of the Miz-1 POZ domain. J Mol Biol 373: 820-826.
45. van Riggelen J, Muller J, Otto T, Beuger V, Yetil A, Choi PS, Kosan C, Moroy T, Felsher DW, Eilers M. 2010. The interaction between Myc and Miz1 is required to antagonize TGF-b-dependent autocrine signaling during lymphoma formation and maintenance. Genes Dev 24: 1281-1294.
46. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, et al. 2003. The F-Box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11: 1189-1200.
47. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR. 2001. Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet 28: 165-168.
48. Wanzel M, Kleine-Kohlbrecher D, Herold S, Hock A, Berns K, Park J, Hemmings B, Eilers M. 2005. Akt and 14-3-3h regulate Miz1 to control cell-cycle arrest after DNA damage. Nat Cell Biol 7: 30-41.
49. Wanzel M, Russ AC, Kleine-Kohlbrecher D, Colombo E, Pelicci PG, Eilers M. 2008. A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat Cell Biol 10: 1051-1061.
50. Ink4b G1 arrest pathway. Mol Cell Biol 19: 5913-5922.
51. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR, Trumpp A. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18: 2747-2763.
52. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG. 2003. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351-360.
53. Zanet J, Pibre S, Jacquet C, Ramirez A, de Alboran IM, Gandarillas A. 2005. Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. J Cell Sci 118: 1693-1704.
54. Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, Zhang Y, Chan JC, Fu K, Marquez VE, et al. 2012. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-cell lymphomas. Cancer Cell 22: 506-523.
55. Ziegelbauer J, Shan B, Yager D, Larabell C, Hoffmann B, Tjian R. 2001. Transcription factor MIZ-1 is regulated via microtubule association. Mol Cell 8: 339-349.
56. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424-2433.